HomeEKTAF • OTCMKTS
add
Elekta AB (publ)
Previous close
$5.92
Day range
$6.15 - $6.15
Year range
$4.48 - $6.29
Market cap
20.92B SEK
Avg Volume
594.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | 4.07B | -6.24% |
Operating expense | 1.16B | 1.57% |
Net income | 230.00M | 8.49% |
Net profit margin | 5.65 | 15.78% |
Earnings per share | 0.64 | 1.59% |
EBITDA | 515.00M | -8.20% |
Effective tax rate | 26.13% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.58B | -23.15% |
Total assets | 28.24B | -13.21% |
Total liabilities | 19.74B | -10.52% |
Total equity | 8.49B | — |
Shares outstanding | 382.08M | — |
Price to book | 0.27 | — |
Return on assets | 3.28% | — |
Return on capital | 5.72% | — |
Cash Flow
Net change in cash
| (SEK) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | 230.00M | 8.49% |
Cash from operations | 637.00M | 39.69% |
Cash from investing | -280.00M | 51.22% |
Cash from financing | -522.00M | -149.90% |
Net change in cash | -184.00M | -118.62% |
Free cash flow | 266.62M | 389.22% |
About
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees. Wikipedia
Founded
1972
Website
Employees
4,484
